Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Invitrogen Corporation gets antibody analysis clearance

Invitrogen Corporation gets antibody analysis clearance

4th June 2008

Invitrogen Corporation has received clearance from the US Food and Drug Administration for its DynaChip Antibody Analysis System.

Representatives for the firm claimed the move validates the accuracy of DynaChip data and demonstrates Invitrogen’s commitment to providing clinicians with "accurate and more efficient solutions".

"The high capacity of the DynaChip allows us to add a larger number of proteins than competitive products, reducing the amount of testing and overall turn-around time," added Jim Janicki, vice-president and general manager of Invitrogen’s Applied Markets business unit.

"With organ donations, time is of the essence and this analysis system will help physicians make fast, reliable clinical decisions."

The DynaChip system is currently the only automated chip-based system for human leukocyte antigen (HLA) antibody detection and identification.

Located on the surface of certain cells in the body, human leukocyte antigens are proteins used by the immune system to identify viruses or bacteria.

HLA antibody identification is important for organ transplant donor-recipient matching as particular patients’ immune systems may fight cells from a donor, ultimately causing organ donation failure or rejection.
ADNFCR-1050-ID-18622444-ADNFCR

We currently have 7 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.